Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Top Cited Papers
- 1 August 2007
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 176 (3) , 277-284
- https://doi.org/10.1164/rccm.200701-044oc
Abstract
From the late 1970s to the early 1990s, studies found that mortality rates for pulmonary fibrosis were increasing. Recent data for mortality from pulmonary fibrosis are unavailable. We sought to determine mortality rates for pulmonary fibrosis in the United States from 1992 through 2003. Using data from the National Center for Health Statistics, we calculated age-adjusted mortality rates from the deaths of persons with pulmonary fibrosis and stratified the data to determine differences in mortality rates by age, sex, race/ethnicity, and geography of the decedent. We developed a multivariable model to predict future mortality rates, and we determined the underlying cause of death in patients with pulmonary fibrosis. From 1992 to 2003, there were 28,176,224 deaths in the United States and 175,088 decedents with pulmonary fibrosis. The average age- and sex-adjusted mortality rate was 50.8 per 1,000,000 people. The age-adjusted mortality rate increased 28.4% in men (from 40.2 deaths per 1,000,000 in 1992 to 61.9 deaths per 1,000,000 in 2003) and 41.3% in women (from 39.0 deaths per 1,000,000 in 1992 to 55.1 deaths per 1,000,000 in 2003). While increases were significant in both men and women (p < 0.0001), the rate of increase was higher in women (p < 0.0001). The most common cause of death in patients with pulmonary fibrosis was the disease itself. From 1992 to 2003, mortality rates for pulmonary fibrosis significantly increased. Further investigation is needed to determine the etiology of these trends, which are predicted to continue to increase.Keywords
This publication has 16 references indexed in Scilit:
- Incidence and Prevalence of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- A Comparison of Underlying Cause and Multiple Causes of DeathEpidemiology, 2006
- High-Dose Acetylcysteine in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2005
- A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2004
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Mortality rates from cryptogenic fibrosing alveolitis in seven countries.Thorax, 1996
- Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data.American Journal of Respiratory and Critical Care Medicine, 1996
- The epidemiology of interstitial lung diseases.American Journal of Respiratory and Critical Care Medicine, 1994
- Rising mortality from cryptogenic fibrosing alveolitis.BMJ, 1990
- Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessmentThe American Journal of Medicine, 1990